Non-invasive assessment of liver fibrosis: The gap between ideal and real

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 6, 2011, Pages 937-939

  Kim, Seung Up ^a,b,c   Han, Kwang Hyub ^a,b,c,d   Ahn, Sang Hoon ^a,b,c,d  

^a Department of Internal Medicine ^*  (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Liver Cirrhosis Clinical Research Centre   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN A1; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; HAPTOGLOBIN; HYALURONIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; EDITORIAL; ELASTOGRAPHY; GOLD STANDARD; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STANDARDIZATION; VIRUS HEPATITIS;

EID: 79955908142     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06741.x     Document Type: Editorial

References (18)

1. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990; 99: 1396-400.
2. Regev A, Berho M, Jeffers LJ etal. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002; 97: 2614-18.
3. Poynard T, Aubert A, Bedossa P etal. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991; 100: 1397-402.
4. Forns X, Ampurdanes S, Llovet JM etal. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-92.
5. Adams LA, Bulsara M, Rossi E etal. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin. Chem. 2005; 51: 1867-73.
6. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006; 43(Suppl. 1): S113-20.
7. Kim BK, Kim SA, Park YN etal. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. Liver Int. 2007; 27: 969-76.
8. Hui AY, Chan HL, Wong VW etal. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am. J. Gastroenterol. 2005; 100: 616-23.
9. Ziol M, Handra-Luca A, Kettaneh A etal. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
10. Kim SU, Ahn SH, Park JY etal. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J. Clin. Gastroenterol. 2009; 43: 267-71.
11. Kim SU, Ahn SH, Park JY etal. Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan) before curative resection of hepatocellular carcinoma: a pilot study. Hepatol. Int. 2008; 2: 471-7.
12. Kim BK, Han KH, Park JY etal. A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver Int. 2010; 30: 1073-81.
13. Lee HJ, Seo YS, Kim DJ etal. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B. J. Gastroenterol. Hepatol. 2011; 26: 987-95.
14. Castera L, Vergniol J, Foucher J etal. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
15. Ngo Y, Munteanu M, Messous D etal. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin. Chem. 2006; 52: 1887-96.
16. Ngo Y, Benhamou Y, Thibault V etal. An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load. PLoS ONE 2008; 3: e2573.
17. Masuzaki R, Tateishi R, Yoshida H etal. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-61.
18. Jung KS, Kim SU, Ahn SH etal. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.